Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
13 Jan 2025 |
AD01 |
Registered office address changed from Nucleome Therapueatics Limited Inventa Botley Road Oxford OX2 0HY United Kingdom to Nucleome Therapeutics Limited, Inventa Botley Road Oxford OX2 0HY on 13 January 2025
|
|
|
10 Jan 2025 |
AD01 |
Registered office address changed from Suite C, Second Floor, Schrodinger Building, Oxford Science Park Oxford OX4 4GE England to Nucleome Therapueatics Limited Inventa Botley Road Oxford OX2 0HY on 10 January 2025
|
|
|
07 Jan 2025 |
AA01 |
Previous accounting period shortened from 31 July 2025 to 31 December 2024
|
|
|
28 Dec 2024 |
AA |
Accounts for a small company made up to 31 July 2024
|
|
|
22 Oct 2024 |
RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 4 October 2024
|
|
|
04 Oct 2024 |
SH01 |
Statement of capital following an allotment of shares on 27 August 2024
-
ANNOTATION
Clarification a second filed SH01 was registered on 22/10/24.
|
|
|
16 Aug 2024 |
CS01 |
Confirmation statement made on 16 August 2024 with updates
|
|
|
09 Aug 2024 |
SH08 |
Change of share class name or designation
|
|
|
01 Aug 2024 |
TM02 |
Termination of appointment of Phil Boyd as a secretary on 26 July 2024
|
|
|
30 Jul 2024 |
AP01 |
Appointment of Mark Bodmer as a director on 24 July 2024
|
|
|
30 Jul 2024 |
SH01 |
Statement of capital following an allotment of shares on 15 July 2024
|
|
|
25 Jun 2024 |
CH01 |
Director's details changed for John Davis on 25 June 2024
|
|
|
31 May 2024 |
CH01 |
Director's details changed for Dr Bauke Anninga on 21 October 2022
|
|
|
31 May 2024 |
CH03 |
Secretary's details changed for Phil Boyd on 21 October 2022
|
|
|
28 May 2024 |
SH01 |
Statement of capital following an allotment of shares on 22 May 2024
|
|
|
16 May 2024 |
AP01 |
Appointment of John Davis as a director on 15 February 2024
|
|
|
16 May 2024 |
TM01 |
Termination of appointment of Danuta Mariola Jeziorska as a director on 19 April 2024
|
|
|
20 Feb 2024 |
PSC05 |
Change of details for Oxford Science Enterprises Plc as a person with significant control on 26 August 2023
|
|
|
15 Feb 2024 |
SH01 |
Statement of capital following an allotment of shares on 14 February 2024
|
|
|
04 Jan 2024 |
AA |
Accounts for a small company made up to 31 July 2023
|
|
|
13 Dec 2023 |
SH01 |
Statement of capital following an allotment of shares on 13 December 2023
|
|
|
08 Nov 2023 |
SH01 |
Statement of capital following an allotment of shares on 8 September 2023
|
|
|
08 Nov 2023 |
SH01 |
Statement of capital following an allotment of shares on 26 August 2023
|
|
|
07 Sep 2023 |
AP01 |
Appointment of Dr Russell George Greig as a director on 6 September 2023
|
|
|
07 Aug 2023 |
CS01 |
Confirmation statement made on 7 August 2023 with updates
|
|